CONMED PE Ratio 2010-2024 | CNMD

Current and historical p/e ratio for CONMED (CNMD) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CONMED PE ratio as of November 13, 2024 is 19.27.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CONMED PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-12 74.77 28.32
2024-09-30 71.92 $2.64 27.24
2024-06-30 69.14 $3.14 22.02
2024-03-31 79.64 $2.61 30.51
2023-12-31 108.64 $2.04 53.25
2023-09-30 99.87 $1.85 53.98
2023-06-30 134.32 $2.83 47.46
2023-03-31 102.51 $-3.25 0.00
2022-12-31 87.30 $-2.84 0.00
2022-09-30 78.77 $-2.95 0.00
2022-06-30 93.89 $-3.96 0.00
2022-03-31 145.34 $2.10 69.21
2021-12-31 138.49 $1.94 71.39
2021-09-30 127.62 $2.00 63.81
2021-06-30 133.85 $1.76 76.05
2021-03-31 127.00 $0.39 325.64
2020-12-31 108.75 $0.28 388.38
2020-09-30 76.24 $-0.04 0.00
2020-06-30 69.61 $-0.04 0.00
2020-03-31 55.22 $1.11 49.75
2019-12-31 107.52 $0.95 113.18
2019-09-30 92.28 $1.00 92.28
2019-06-30 81.96 $0.97 84.50
2019-03-31 79.48 $1.15 69.12
2018-12-31 61.19 $2.76 22.17
2018-09-30 75.28 $2.48 30.36
2018-03-31 59.87 $2.50 23.95
2017-12-31 48.03 $1.97 24.38
2017-09-30 49.25 $0.56 87.95
2017-06-30 47.63 $0.56 85.06
2017-03-31 41.37 $0.44 94.02
2016-12-31 40.94 $0.52 78.74
2016-09-30 36.97 $0.56 66.02
2016-06-30 43.83 $0.62 70.69
2016-03-31 38.33 $0.79 48.52
2015-12-31 40.07 $1.17 34.25
2015-09-30 43.21 $1.30 33.24
2015-06-30 52.54 $1.05 50.04
2018-06-30 69.39 $1.15 60.34
2014-12-31 40.24 $1.16 34.69
2014-09-30 32.82 $1.11 29.57
2014-06-30 39.14 $1.27 30.82
2014-03-31 38.35 $1.10 34.86
2013-12-31 37.34 $1.13 33.05
2015-03-31 45.37 $1.14 39.79
2013-09-30 29.69 $1.29 23.01
2013-06-30 27.18 $1.41 19.28
2013-03-31 29.50 $1.42 20.78
2012-12-31 24.10 $0.15 160.65
2012-09-30 24.44 $0.06 407.29
2012-03-31 25.33 $0.04 633.26
2011-12-31 21.66 $-0.00 0.00
2011-09-30 19.41 $1.14 17.03
2011-06-30 24.03 $1.21 19.86
2011-03-31 22.17 $1.22 18.17
2010-12-31 22.30 $1.16 19.22
2012-06-30 23.60 $1.17 20.17
2010-09-30 18.91 $0.98 19.29
2010-06-30 15.72 $0.71 22.14
2010-03-31 20.09 $0.51 39.39
2009-12-31 19.24 $0.41 46.92
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.310B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.406B 21.40
Becton Dickinson (BDX) United States $66.847B 17.57
Cardinal Health (CAH) United States $29.891B 16.21
West Pharmaceutical Services (WST) United States $23.731B 48.47
Labcorp (LH) United States $20.430B 16.94
Cooper (COO) United States $20.314B 28.92
Align Technology (ALGN) United States $16.356B 31.30
Henry Schein (HSIC) United States $8.411B 16.02
Merit Medical Systems (MMSI) United States $6.075B 31.02
DENTSPLY SIRONA (XRAY) United States $3.532B 9.61
Patterson (PDCO) United States $1.830B 9.66
STAAR Surgical (STAA) United States $1.430B 52.76
Lifevantage (LFVN) United States $0.172B 22.90
Pro-Dex (PDEX) United States $0.162B 32.17